Does interleukin-18 or tumour necrosis factor-α have an independent association with the risk of coronary heart disease? Results from a prospective study in New Zealand

被引:22
作者
Welsh, Paul
Woodward, Mark [2 ,3 ]
Rumley, Ann
MacMahon, Steve [2 ]
Lowe, Gordon D. [1 ]
机构
[1] Univ Glasgow, Glasgow Royal Infirm, Div Cardiovasc & Med Sci, Glasgow G31 2ER, Lanark, Scotland
[2] Univ Sydney, George Inst, Sydney, NSW 2006, Australia
[3] Mt Sinai Med Ctr, New York, NY 10029 USA
基金
英国医学研究理事会;
关键词
IL-18; TNF alpha; Inflammation; Coronary heart disease; Risk markers; C-REACTIVE PROTEIN; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; RHEUMATOID-ARTHRITIS; INFLAMMATORY MARKERS; INCIDENT CORONARY; UNSTABLE ANGINA; WOMEN; MICE; EXPRESSION;
D O I
10.1016/j.cyto.2009.12.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The pro-inflammatory cytokines, interleukin (IL)-18 and tumour necrosis factor-alpha (TNF alpha) may play a role in coronary heart disease (CHD). We aimed to extend data on their relationships to the risk of CHD in generally healthy populations. Methods: During 5.5 years follow-up in the Fletcher Challenge general population cohort there were 256 CHD cases, and 615 controls were matched for age and sex. Baseline plasma levels of IL-18 and INF alpha were related to CHD risk in available samples (77%). Results: Plasma levels of IL-18 (11% increase in mean, p = 0.01) and TNF alpha (10% increase in mean p = 0.024) were significantly elevated in CHD cases versus controls. In univariable models IL-18 was associated with CHD risk (odds ratio [OR] upper third to lower third, 1.63; 95% Cl 1.08, 2.46), but TNF alpha was not (OR 1.33; 95% Cl 0.87, 2.02). After adjusting for major CHD risk factors and CRP, the association of IL-18 with CHD risk was attenuated (OR 1.69; 95% Cl 0.94, 3.03). Conclusions: IL-18, but not TNF alpha, had a non-negligible association with CHD risk, although the association of IL-18 with risk was weak after full adjustment. These cytokines may play a role in CHD pathology, but may not be robust risk biomarkers. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:94 / 98
页数:5
相关论文
共 31 条
  • [1] BEUTLER BA, 1985, J IMMUNOL, V135, P3972
  • [2] Interleukin-18 and the risk of coronary heart disease in European men -: The Prospective Epidemiological Study of Myocardial Infarction (PRIME)
    Blankenberg, S
    Luc, G
    Ducimetière, P
    Arveiler, D
    Ferrières, J
    Amouyel, P
    Evans, A
    Cambien, F
    Tiret, L
    [J]. CIRCULATION, 2003, 108 (20) : 2453 - 2459
  • [3] Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina
    Blankenberg, S
    Tiret, L
    Bickel, C
    Peetz, D
    Cambien, F
    Meyer, J
    Rupprecht, HJ
    [J]. CIRCULATION, 2002, 106 (01) : 24 - 30
  • [4] Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study
    Blankenberg, Stefan
    McQueen, Matthew J.
    Smieja, Marek
    Pogue, Janice
    Balion, Cynthia
    Lonn, Eva
    Rupprecht, Hans J.
    Bickel, Christoph
    Tiret, Laurence
    Cambien, Francois
    Gerstein, Hertzel
    Muenzel, Thomas
    Yusuf, Salim
    [J]. CIRCULATION, 2006, 114 (03) : 201 - 208
  • [5] Exclusive expression of transmembrane TNF-α in mice reduces the inflammatory response in early lipid lesions of aortic sinus
    Canault, M
    Peiretti, F
    Mueller, S
    Kopp, F
    Morange, P
    Rihs, S
    Portugal, H
    Juhan-Vague, I
    Nalbone, G
    [J]. ATHEROSCLEROSIS, 2004, 172 (02) : 211 - 218
  • [6] Inflammatory markers and onset of cardiovascular events - Results from the Health ABC study
    Cesari, M
    Penninx, BWJH
    Newman, AB
    Kritchevsky, SB
    Nicklas, BJ
    Sutton-Tyrrell, K
    Rubin, SM
    Ding, JZ
    Simonsick, EM
    Harris, TB
    Pahor, M
    [J]. CIRCULATION, 2003, 108 (19) : 2317 - 2322
  • [7] C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
    Danesh, J
    Wheeler, JG
    Hirschfield, GM
    Eda, S
    Eiriksdottir, G
    Rumley, A
    Lowe, GDO
    Pepys, MB
    Gudnason, V
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) : 1387 - 1397
  • [8] Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor α therapy -: Results from the British Society for Rheumatology Biologics Register
    Dixon, W. G.
    Watson, K. D.
    Lunt, M.
    Silman, A. J.
    Hyrich, K. L.
    Symmons, D. P. M.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (09): : 2905 - 2912
  • [9] Inflammation, atherosclerotic burden and cardiovascular prognosis
    Espinola-Klein, Christine
    Rupprecht, Hans J.
    Bickel, Christoph
    Lackner, Karl
    Schnabel, Renate
    Munzel, Thomas
    Blankenberg, Stefan
    [J]. ATHEROSCLEROSIS, 2007, 195 (02) : E126 - E134
  • [10] Interleukin-18 and the risk of future cardiovascular disease among initially healthy women
    Everett, Brendan M.
    Bansal, Sandeep
    Rifai, Nader
    Buring, Julie E.
    Ridker, Paul M.
    [J]. ATHEROSCLEROSIS, 2009, 202 (01) : 282 - 288